Site icon BioInformant

University of Miami Researchers Present the Latest at the American Association of Stem Cell Physicians (AAOSCP) Annual Summit

August 16, 2018, Miami, FL — The American Association of Stem Cell Physicians (AAOSCP) concluded a highly successful annual summit held from August 10 – 12, 2018, in Miami, FL. Attended by a global audience, the event featured researchers from the University of Miami who presented the latest research on stem cell applications.

The spokesperson for American Association of Stem Cell Physicians, A.J. Farshchian, MD, stated: “The American Association of Stem Cell Physicians is solely committed to create an educational platform based on solid foundational research. Our goal is to enhance the quality of medical practice and the continued education of physicians. Currently, we are the most research oriented group representing academia, clinical researchers and physicians from around the world. Our goal is to make available to physicians the benefit of stem cell therapeutics, to share ideas and techniques, to make stem cells the standard of care in the near future, to obtain funding for scientifically sound and innovative research, to develop innovative and diagnostic tools based on scientific research, and to assist in funding and promotion of research based cell therapies.”

Dr Ivonne Schulman of the University of Miami presenting at 2018 AAOSCP Summit.

A leading researcher from the University of Miami, Dr Ivonne Schulman, presented at the summit on the mechanisms underlying the cardiovascular regenerative capacity of stem cells. Her laboratory at the University of Miami, Miller School of Medicine, is focused the effect of circulating factors and aging on stem cell growth and differentiation, as it relates to cardiovascular health. Other University of Miami researchers presenting at the event included: Dr Alfanso Sabater; Ian White, Ph.D., Lee Kaplan, MD; and Randy Miller, MD, among others.

Dr Jeffrey Weiss, who performed the first retinal stem cell surgery in 2010, lectured on the use of stem cells for retinal regeneration. Dr. Weiss is the Principal Investigator of the Stem Cell Ophthalmology Treatment Study (SCOTS), a study evaluating the use of autologous bone marrow derived stem cells for the treatment of retinal and optic nerve damage or disease. He is also chairman of the Regenerative Ophthalmology Committee, as well as AASCP Vice President and Vice Chairman of the Scientific Committee.

The conference featured three days of educational events with leading physicians and pioneers in the fields of stem cells and regenerative medicine. At the event, attendees met, workshopped, and networked with prominent doctors and scientists from around the world. In total, the summit showcased more than 40 world-class speakers who are leading practitioners and researchers in the fields of stem cell therapy and science.

About the American Association of Stem Cell Physicians

The American Association of Stem Cell Physicians (AAOSCP) is an organization created to advance research and the development of therapeutics in regenerative medicine, including diagnosis, treatment, and prevention of disease related to or occurring within the human body. The AAOSCP aims to serve as an educational resource for physicians, scientists, and the public in diseases that can be caused by physiological dysfunction that are ameliorable to medical treatment.

Source: American Association of Stem Cell Physicians (AAOSCP)

4.9/5 - (17 votes)
Exit mobile version